Breast cancer is the second most commonly diagnosed cancer. Because there are many different types of breast cancer and several ways to treat the disease, CURE Connections wants to answer the questions you might have following a recent diagnosis. Throughout this program, you will hear about the different testing procedures that are available for screening, what to do once diagnosed, and how to find the best possible care team, from expert oncologists and breast cancer patients.
Adam M. Brufsky, MD, PhD, and Lynn Acierno, BSN, RN, OCN, RN-BC, highlight breast cancer subtypes and the diagnostic tests used to confirm a diagnosis and discuss how they educate patients on their prognosis.
Kisqali (ribociclib) was granted a breakthrough therapy designation by the Food and Drug Administration (FDA) to be used in combination with tamoxifen or an aromatase inhibitor (AI) in the frontline treatment of pre- or perimenopausal women who have hormone receptor-positive HER2-negative advanced or metastatic breast cancer.